stockportfolio.pro
Stocks / COO vs IONS
COO vs IONS
The Cooper Companies, Inc. and Ionis Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
COO is the larger company ($12.7B vs $12.2B). On the fundamentals, COO grows revenue faster (11.0% vs 5.3%); COO earns a higher net margin (9.2% vs -40.4%); COO has the stronger return on equity (4.6% vs -78.0%). Full numbers below — the stronger figure on each row is in green.
| The Cooper Companies, Inc. (COO) | Ionis Pharmaceuticals, Inc. (IONS) | |
|---|---|---|
| Market cap | $12.7B | $12.2B |
| Revenue (latest FY) | $4.09B | $943.71M |
| Net income (latest FY) | $374.90M | $-381.39M |
| Revenue growth (5y CAGR) | 11.0% | 5.3% |
| Net margin | 9.2% | -40.4% |
| Return on equity | 4.6% | -78.0% |
| P/E ratio | 55.1 | — |
| Dividend yield | — | — |
| Profitable years (of last 10) | 10 | 3 |
| Positive free cash flow | Yes | No |
Compare with another company:
See the full COO vs IONS breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open COO's full financials → Open IONS's full financials →More comparisons
Frequently asked questions
Which is bigger, COO or IONS?
The Cooper Companies, Inc. is larger by market capitalization — $12.7B versus $12.2B.
Which grows faster, COO or IONS?
Over the last five fiscal years, The Cooper Companies, Inc. grew revenue faster — 11.0%/yr versus 5.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.